A detailed history of Harris Associates L P transactions in Becton Dickinson & CO stock. As of the latest transaction made, Harris Associates L P holds 3,115,375 shares of BDX stock, worth $595 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
3,115,375
Previous 2,917,284 6.79%
Holding current value
$595 Million
Previous $503 Million 16.04%
% of portfolio
0.96%
Previous 0.85%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$172.41 - $199.66 $34.2 Million - $39.6 Million
198,091 Added 6.79%
3,115,375 $583 Million
Q2 2025

Aug 14, 2025

BUY
$165.15 - $226.42 $268 Million - $368 Million
1,625,391 Added 125.81%
2,917,284 $503 Million
Q1 2025

May 15, 2025

BUY
$222.79 - $249.08 $88.8 Million - $99.3 Million
398,538 Added 44.61%
1,291,893 $296 Million
Q4 2024

Feb 14, 2025

BUY
$220.02 - $243.75 $197 Million - $218 Million
893,355 New
893,355 $203 Billion

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $54.5B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Harris Associates L P Portfolio

Follow Harris Associates L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harris Associates L P, based on Form 13F filings with the SEC.

News

Stay updated on Harris Associates L P with notifications on news.